Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;135(Suppl 1):53-61.
doi: 10.1007/s00508-023-02165-9. Epub 2023 Apr 20.

[Insulin pump therapy and continuous glucose monitoring]

[Article in German]
Affiliations

[Insulin pump therapy and continuous glucose monitoring]

[Article in German]
Ingrid Schütz-Fuhrmann et al. Wien Klin Wochenschr. 2023 Jan.

Abstract

This Guideline represents the recommendations of the Austrian Diabetes Association (ÖDG) on the use of diabetes technology (insulin pump therapy; continuous glucose monitoring, CGM; hybrid closed-loop systems, HCL; diabetes apps) and access to these technological innovations for people with diabetes mellitus based on current scientific evidence.

Diese Leitlinie repräsentiert die Empfehlungen der Österreichischen Diabetes Gesellschaft (ÖDG) zur Nutzung von Diabetes-Technologie (Insulinpumpentherapie; kontinuierliche Glukosemesssysteme, CGM; Hybrid Closed Loop Systeme, HCL; Automated Insulin Delivery Systeme, AID, Diabetes-Apps) und den Zugang zu diesen technologischen Innovationen für Menschen mit Diabetes mellitus. Die Leitlinie wurde basierend auf aktueller wissenschaftlicher Evidenz erstellt.

Keywords: AID; Artificial pancreas; CGM; Closed-loop; Diabetes technology; Insulin pump therapy; Mobile apps; Telemedicine; Threshold-suspension.

PubMed Disclaimer

References

Literatur

    1. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25(7):765–774. doi: 10.1111/j.1464-5491.2008.02486.x. - DOI - PubMed
    1. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012;157(5):336–347. doi: 10.7326/0003-4819-157-5-201209040-00508. - DOI - PubMed
    1. Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia. 2008;51(6):941–951. doi: 10.1007/s00125-008-0974-3. - DOI - PubMed
    1. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009;94(3):729–740. doi: 10.1210/jc.2008-1415. - DOI - PubMed
    1. Pańkowska E, Błazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10(1):52–58. doi: 10.1111/j.1399-5448.2008.00440.x. - DOI - PubMed
Weiterführende Literatur
    1. Collyns O, et al. improvd glycemic outcomes with medtronic minimed advanced hybrid closed loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care. 2021;44(4):969–975. doi: 10.2337/dc20-2250. - DOI - PubMed

Publication types

MeSH terms